Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab Induction and Maintenance in Plaque Psoriasis
NCT00106834Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of infliximab in plaque psoriasis, sponsored by Janssen Pharmaceutical. Status: completed.
02
Drugs
infliximab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00106834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00106834.